NIH grants Genesis non-exclusive, worldwide rights to 22 U.S. and 21 foreign patents and patent applications related to autologous cell therapy to treat cancer

National Institutes of Health

U.S. / Government

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Genesis Biopharma Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced